The startup develops optical imaging devices that enhance the resolution of Optical Coherence Tomography (OCT) for three-dimensional tomography. This technology provides dermatologists and pathologists with faster and more accurate diagnostic capabilities, improving patient outcomes and research efficiency.
Funding
$10.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional diagnostic methods for skin conditions often rely on invasive biopsies, which are time-consuming, can cause patient discomfort, and only provide a limited two-dimensional view of the tissue structure. Existing non-invasive imaging techniques lack the resolution to visualize cellular-level details, hindering accurate and early diagnosis of skin diseases.
Solution
Apollo Medical Optics develops advanced optical imaging systems based on Full-Field Optical Coherence Tomography (FF-OCT) to provide high-resolution, real-time, three-dimensional visualization of skin structures. Their flagship products, including the ApolloVue® S100, SeeKIN, and ApolloVue® B100, offer non-invasive alternatives to traditional biopsies, enabling clinicians to examine cellular features in-vivo. These systems utilize a unique crystal fiber light source and Mirau-based interferometry to achieve micron-scale resolution in both axial and lateral directions. By integrating FF-OCT with artificial intelligence, Apollo Medical Optics enhances image quality, automates feature detection, and provides quantitative analysis of skin conditions, leading to improved diagnostic accuracy and treatment monitoring.
Target Audience
The primary target audience includes dermatologists, pathologists, aesthetic medicine practitioners, and clinical researchers who require high-resolution, non-invasive imaging tools for skin diagnosis, treatment monitoring, and research applications.
Features
- Non-invasive imaging of skin at cellular resolution, reducing the need for biopsies
- Real-time 3D imaging for comprehensive visualization of tissue microstructure
- Unique crystal fiber light source for high brightness, broad bandwidth, and optimal image quality
- Mirau-based FF-OCT system for increased scanning speed and depth
- Dual-mode scanning (cross-sectional B-scan and en face E-scan) for versatile imaging
- Image guiding system with image registration and precise positioning for accurate targeting and tracking
- AI-powered image de-noising and feature quantification for enhanced analysis
- Automated detection of melanin accumulation and nuclei for melasma diagnosis and research